<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170423033606N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-25</date_registration>
      <primary_sponsor>Cognitive Sciences &amp; Technologies Council</primary_sponsor>
      <public_title>The effect of Prism Adaption and the Trans-cranial Magnetic Stimulation in spatial neglect treatment</public_title>
      <acronym>cognitive rehabilitation Trans-cranial Magnetic Stimulation (TMS) Prism Adaption (PA)</acronym>
      <scientific_title>Comparison of the effectiveness of cognitive rehabilitation of stroke patients with spatial neglect using the Prism Adaption and combined Prism Adaption and the Trans-cranial Magnetic Stimulation: a randomized control clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-07-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>18</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/25878</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be assigned to one of two groups with the help of random numbers table, Blinding description: After randomization, intervention group patients will receive trans cranial magnetic stimulation (TMS) with the following protocol: 801 pulses will be delivered in 267 bursts and each burst consisted of 3 pulses at 30 Hz. Each session of stimulation will last 45 seconds as stimulation bursts will be delivered at 6 Hz. Magnetic coil will be tangentially placed at P3, with the handle pointing posterior. Sham group patients will receive the same stimulation protocol and the magnetic coil will be placed at P3. The only difference will be holding the magnetic coil vertical to the scalp that will resulted in no brain stimulation during the stimulation period. However, patients will hear magnetic pulses' sounds (clicks) without receiving any stimulation.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Stroke with unilateral spatial neglect.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In each session, patients will receive trans cranial magnetic stimulation (TMS). Inhibitory TMS will be as following protocol: 801 pulses will be delivered in 267 bursts and each burst will consist of 3 pulses at 30 Hz. Each session of stimulation will last 45 seconds as stimulation bursts will deliver at 6 Hz. Magnetic coil will place tangentially at P3 and the coil handle will be placed in posterior. After stimulation, patients will receive mirror therapy for 20 minutes while will wear prism glasses. Prism adaption glasses will deviate the visual fields 10 degrees to the right. In each 20 minutes of mirror therapy, patients will sit at a table containing a vertical mirror with the size of 35*35*30 cm. Patients will be asked to put their pare tic hands inside the mirror box and their intact hand in front, so mirror image of the intact hand will seem as the pare tic hand in the patients' eyes. Then, patients will open and close their hands and fingers while will look at their hands' images in the mirror. Also, they will try to do the same movements with their pare tic hands meanwhile. This therapy will continue for 10 daily sessions in 2 weeks. Intervention 2: Sham stimulation control group: In each session, patients will receive trans cranial magnetic stimulation (TMS). Inhibitory TMS will be as following protocol: 801 pulses will deliver in 267 bursts and each burst will consist of 3 pulses at 30 Hz. Each session of stimulation will last 45 seconds as stimulation bursts will deliver at 6 Hz. Magnetic coil will couple vertically place at P3, with the handle will be placed at posterior. After stimulation, patients will receive mirror therapy for 20 minutes while will wear prism glasses. Prism adaption glasses will deviate the visual fields 10 degrees to the right. In each 20 minutes of mirror therapy, patients will sit at a table contain a vertical mirror in size of 35*35*30 cm. Patients will ask to put their pare tic hands inside the mirror box and their intact hand in front, so mirror image of the intact hand will seem as the pare tic hand to the patients' eyes. Then, patients will open and close their hands and fingers while will look at their hands' images in the mirror. Also, they will try to do the same movements with their pare tic hands meanwhile. This therapy will be done during 10 daily sessions for 2 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>SHole Vatanparasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Block 16., Imam Hossein university., Shahid Babai Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5716847146</zip>
        <telephone>+98 214433839881</telephone>
        <email>sholevatanparast100@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>SHole Vatanparasti</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Block 16., Imam Hossein university., Shahid Babai Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5716847146</zip>
        <telephone>+98 214433839881</telephone>
        <email>sholevatanparast100@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The right-handed patients
stroke in right hemisphere with unilateral neglect</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Minimum age 18 and Maximum age 80 years
intense pain
cerebral edema
brain trauma
pacemaker of heart
National Institutes of Health Stroke scale</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I64</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stroke, not specified as hemorrhage or infarction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In each session, patients will receive trans cranial magnetic stimulation (TMS). Inhibitory TMS will be as following protocol: 801 pulses will be delivered in 267 bursts and each burst will consist of 3 pulses at 30 Hz. Each session of stimulation will last 45 seconds as stimulation bursts will deliver at 6 Hz. Magnetic coil will place tangentially at P3 and the coil handle will be placed in posterior. After stimulation, patients will receive mirror therapy for 20 minutes while will wear prism glasses. Prism adaption glasses will deviate the visual fields 10 degrees to the right. In each 20 minutes of mirror therapy, patients will sit at a table containing a vertical mirror with the size of 35*35*30 cm. Patients will be asked to put their pare tic hands inside the mirror box and their intact hand in front, so mirror image of the intact hand will seem as the pare tic hand in the patients' eyes. Then, patients will open and close their hands and fingers while will look at their hands' images in the mirror. Also, they will try to do the same movements with their pare tic hands meanwhile. This therapy will continue for 10 daily sessions in 2 weeks.</i_keyword>
      <i_keyword>Sham stimulation control group: In each session, patients will receive trans cranial magnetic stimulation (TMS). Inhibitory TMS will be as following protocol: 801 pulses will deliver in 267 bursts and each burst will consist of 3 pulses at 30 Hz. Each session of stimulation will last 45 seconds as stimulation bursts will deliver at 6 Hz. Magnetic coil will couple vertically place at P3, with the handle will be placed at posterior. After stimulation, patients will receive mirror therapy for 20 minutes while will wear prism glasses. Prism adaption glasses will deviate the visual fields 10 degrees to the right. In each 20 minutes of mirror therapy, patients will sit at a table contain a vertical mirror in size of 35*35*30 cm. Patients will ask to put their pare tic hands inside the mirror box and their intact hand in front, so mirror image of the intact hand will seem as the pare tic hand to the patients' eyes. Then, patients will open and close their hands and fingers while will look at their hands' images in the mirror. Also, they will try to do the same movements with their pare tic hands meanwhile. This therapy will be done during 10 daily sessions for 2 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: Line Bisection Test; Star Cancellation Test; The Catherine Bergego Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Neurological function. Timepoint: Before and after 10 session treatment. Method of measurement: The Modified Rankin Scale and The Barthel Index Scale.</sec_outcome>
      <sec_outcome>Writing errors of unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: The Writing Test.</sec_outcome>
      <sec_outcome>Painting of unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: The Painting Coloring Test.</sec_outcome>
      <sec_outcome>Reading of unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: The Reading Test.</sec_outcome>
      <sec_outcome>Copying shape of unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: The O’clock Test  and The Copying Shape.</sec_outcome>
      <sec_outcome>Aphasia of unilateral neglect:;. Timepoint: Before and after 10 session treatment:;. Method of measurement: Persian Diagnostic Aphasia Battery-Aphasia Quotient Test,Persian Picture Naming Battery Test, Picture Naming.</sec_outcome>
      <sec_outcome>Memory of unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: Wechsler Memory Scale: Sub Test, River Mill Scale: Sub Test, Rey Auditory Verbal Learning Test.</sec_outcome>
      <sec_outcome>Spatial ability unilateral neglect. Timepoint: Before and after 10 session treatment. Method of measurement: Mental Rotation Test,Visualizing Test and Water Level Test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Cognitive Sciences &amp; Technologies Council</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-05-13</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Between Sheikh Fazlollah Noori and Shahid Chamran highway, Shahid Hemmat high way Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
